DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

DGX Quest Diagnostics Incorporated

Healthcare

Price
$228.39
Intrinsic value
$75.03
Buy price
$60.02
Discount
-204.4%
Overvalued

Live signals

Daily bars as of Oct 8, 2026

Nothing firing right now - no PAM pattern in the last 5 daily bars, and no DR1 support reclaim in the last 5 weekly bars. Technical confluence is WEAK (1/3) - see the chart below.

DCF walkthrough

Near-term growth (g1)3.16%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$1,903,000,000.00
Total debt
$6,403,999,744.00
Cash & STI
$626,000,000.00
Shares out.
112,000,000
Overvalued
Intrinsic value$75.03
Buy price (with MOS)$60.02
Current price$228.39
Discount to intrinsic value-204.4%

7-step quality scorecard

ROE quality
LOW
Average ROE
14.1%
Current ROE
13.8%
Minimum ROE
12.9%
Debt quality
MODERATE
Debt / Equity
0.89x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.80x

Technical chart

Confluence: WEAK (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(cfCAGR,revenueCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
44.7%
Public economic interest
98.4%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.